Editas Medicine (EDIT) Profit After Tax Growth (5y) (2020 - 2025)
Editas Medicine (EDIT) Profit After Tax Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Editas Medicine | 243.69 Mn | 97.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -39.13% |
| Jun 30, 2025 | -17.70% |
| Mar 31, 2025 | -15.06% |
| Dec 31, 2024 | -3.75% |
| Sep 30, 2024 | -13.53% |
| Jun 30, 2024 | -14.88% |
| Mar 31, 2024 | -16.19% |
| Dec 31, 2023 | 5.51% |
| Sep 30, 2023 | -24.19% |
| Jun 30, 2023 | -0.80% |
| Mar 31, 2023 | -9.65% |
| Dec 31, 2022 | -10.91% |
| Sep 30, 2022 | 7.91% |
| Jun 30, 2022 | 1.46% |
| Mar 31, 2022 | -10.19% |
| Dec 31, 2021 | -1.03% |
| Sep 30, 2021 | -13.21% |
| Jun 30, 2021 | -23.75% |
| Mar 31, 2021 | -26.17% |
| Dec 31, 2020 | -37.68% |